Arrowhead Pharmaceuticals Inc (ARWR)

Net profit margin

Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
Net income (ttm) US$ in thousands -599,493 -538,636 -470,789 -296,814 -205,275 -181,107 -150,207 -154,516 -176,063 -153,926 -111,804 -182,988 -140,848 -125,907 -109,594 -102,612 -84,553 -24,415 9,532 53,265
Revenue (ttm) US$ in thousands 3,551 14,386 25,053 166,263 225,258 245,998 267,743 278,338 243,231 249,939 263,418 144,424 138,288 107,638 89,123 79,841 87,993 123,653 138,974 163,593
Net profit margin -16,882.37% -3,744.17% -1,879.17% -178.52% -91.13% -73.62% -56.10% -55.51% -72.39% -61.59% -42.44% -126.70% -101.85% -116.97% -122.97% -128.52% -96.09% -19.74% 6.86% 32.56%

September 30, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-599,493K ÷ $3,551K
= -16,882.37%

Arrowhead Pharmaceuticals Inc has displayed a fluctuating net profit margin over the past few years, with some periods showing negative margins. In the most recent quarter, the net profit margin was at a significantly negative level of -16,882.37%, indicating that the company's expenses exceeded its revenues by a large margin. This is a concerning trend and may suggest issues with cost management or revenue generation. It is important for the company to closely monitor and address the factors contributing to such low profitability to improve its financial performance and sustainability in the long term.


Peer comparison

Sep 30, 2024